RVL Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| XTX TOPCO LTD | 02/13/2024 | 180,566 | $542 | 100.00% | 0.18% |
| RAYMOND JAMES & ASSOCIATES | 01/16/2024 | 23,696 | $71 | 100.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 03/11/2024 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/16/2024 | 0 | $0 | -100.00% | 0.00% |
| CANTOR FITZGERALD, L. P. | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 01/29/2024 | 0 | $0 | -100.00% | 0.00% |
| BLACKSTONE INC. | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 01/16/2024 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 0 | $0 | -100.00% | 0.00% |
| ATHYRIUM CAPITAL MANAGEMENT, LP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| INSIGHT ADVISORS, LLC/ PA | 01/23/2024 | 0 | $0 | -100.00% | 0.00% |
| DAKOTA COMMUNITY BANK & TRUST NA | 01/10/2024 | 0 | $0 | -100.00% | 0.00% |
| TITLEIST ASSET MANAGEMENT, LLC | 02/15/2024 | 0 | $0 | -100.00% | 0.00% |
RVL Pharmaceuticals plcinstitutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of RVL Pharmaceuticals plc. The most heavily invested institutionals were:
TITLEIST ASSET MANAGEMENT, LTD.: 92,503
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 19,020
Alambic Investment Management, L.P.: 12,516
OppenheimerFunds, Inc.: 38,890
TIAA CREF INVESTMENT MANAGEMENT LLC: 0
TEACHERS ADVISORS, LLC: 0
0.21% of RVL Pharmaceuticals plc stock is owned by institutional investors.
Institutional investors have bought a total of 162,929 shares in the last 24 months. This purchase volume represents approximately $4,888 in transactions.